High Relaxivity Contrast Agent for Cardiac MR in the Myocardial Scar Assessment
Latest Information Update: 14 Apr 2025
At a glance
- Drugs Gadopiclenol (Primary)
- Indications Fibrosis; Myocardial disorders
- Focus Diagnostic use
Most Recent Events
- 09 Apr 2025 Planned initiation date changed from 15 Apr 2025 to 15 Jun 2025.
- 05 Feb 2025 Planned initiation date changed from 15 Feb 2025 to 15 Apr 2025.
- 09 Dec 2024 Planned initiation date changed from 15 Dec 2024 to 15 Feb 2025.